Sanofi expands on Innate tumor collab with fresh $1.44B deal for more NK engagers

After signing a collaboration with fellow French company Innate Pharma in 2016 to develop natural killer (NK) cell engagers, Sanofi is paying 25 million euros upfront for a second order.